Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksNorcros Regulatory News (NXR)

Share Price Information for Norcros (NXR)

Share Price is delayed by 15 minutes
Get Live Data
304.00    -7.00 (-2.25%)
Bid:
334.00
Ask:
284.00
Spread: -50.00 (-14.97%)
Market Cap: £273.26m
NXR Live PriceLast checked at - London Stock Exchange

Intraday Norcros Share Chart

Directors Dealing

27 Jul 2016 17:21

RNS Number : 4421F
Norcros PLC
27 July 2016
 

27 July 2016

Norcros plc

("Norcros" or "the Company")

 

 Directors' Dealings - APSP Share Option and Deferred Share awards

 APSP Share Option Awards

Norcros announces that the Remuneration Committee of the Company has today granted the following HMRC approved and unapproved share option awards (the "APSP Awards") to the Executive Directors of the Company under the Company's Approved Performance Share Plan (the "APSP") over ordinary shares of ten pence each in the Company ("Ordinary Shares").

Name/Position

Number of Ordinary Shares subject to the APSP Award

Option Exercise Price

Nick Kelsall

Group Chief Executive

232,356 (HMRC unapproved)

Nil

Shaun Smith

Group Finance Director

20,000 (HMRC approved)

150 pence

Shaun Smith

Group Finance Director

136,060 (HMRC unapproved)

Nil

 

Under the APSP, awards are made subject to performance targets relating to the Company's diluted underlying Earnings Per Share ("EPS"). Vesting of these shares is subject to achieving aggregate EPS over a three year performance period, starting with the 2017 financial year.

The APSP Awards will normally vest on the third anniversary of their grant, subject to satisfactory achievement of the performance targets. No consideration was paid for the APSP Awards and the consideration due to be payable on vesting will be the option exercise price (if any) shown above.

Bonus payment - Deferred Share Awards

Under the annual bonus scheme, 50 per cent. of an Executive Director's total bonus for the year is satisfied in cash, with the other 50 per cent. in the form of nil cost options under the Company's Deferred Share Bonus Plan (the "Deferred Plan"). These options represent 50 per cent. of the bonuses earned by the Executive Directors for the 2016 financial year. The previous Group Finance Director's entitlement to this award lapsed on his resignation, effective 12 May 2016.

Norcros therefore also announces that the Remuneration Committee has today granted the following nil cost share option awards in respect of the year ended 31 March 2016 (the "Deferred Awards") to the relevant Executive Director of the Company over ordinary shares of ten pence each in the Company ("Ordinary Shares").

Name/Position

Number of Ordinary Shares subject to the Deferred Plan Award

Nick Kelsall

Group Chief Executive

92,544

 

The Deferred Awards will normally vest on the third anniversary of their grant. Because these shares represent part of a bonus already earned, no consideration was paid for the Deferred Awards and no consideration is due to be payable on vesting.

Other information:

Norcros plc LEI: 213800EIMJZZA1GB1E18

Ordinary Shares identity code: GB00BYYJL418

Date of transaction: 27 July 2016

Place of transaction: Wilmslow, Cheshire, England

Further enquiries:

Norcros plc

Tel: 01625 547 700

Nick Kelsall, Group Chief Executive

Shaun Smith, Group Finance Director

 

 

 

Hudson Sandler

Tel: 0207 796 4133

Nick Lyon

 

Charlie Jack

 

Katie Cohen

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHPGURAMUPQGAM
Date   Source Headline
15th Aug 20177:00 amRNSDirector Declaration
31st Jul 20178:49 amRNSHolding(s) in Company
27th Jul 20173:35 pmRNSResult of AGM
27th Jul 20177:00 amRNSAGM Trading Statement
26th Jul 201712:31 pmRNSTotal Voting Rights
23rd Jun 201711:23 amRNSAnnual Financial Report and Notice of AGM
22nd Jun 201711:33 amRNSAdditional Listing
16th Jun 201712:38 pmRNSHolding(s) in Company
14th Jun 20177:00 amRNSResults for the year ended 31 March 2017
12th May 201712:51 pmRNSHolding(s) in Company
18th Apr 20179:18 amRNSHolding(s) in Company
12th Apr 20177:00 amRNSTrading Update
31st Mar 20173:17 pmRNSTotal Voting Rights
21st Mar 20177:17 amRNSHolding(s) in Company
20th Mar 20175:53 pmRNSHolding(s) in Company
9th Feb 20175:18 pmRNSHolding(s) in Company
18th Jan 20171:04 pmRNSHolding(s) in Company
12th Jan 201712:15 pmRNSHolding(s) in Company
16th Dec 20169:29 amRNSEmployee SAYE awards and director shareholding
17th Nov 20167:00 amRNSInterim Results
8th Nov 20162:25 pmRNSDirector Declaration
3rd Nov 20162:03 pmRNSHolding(s) in Company
21st Oct 201612:07 pmRNSSecond Price Monitoring Extn
21st Oct 201612:02 pmRNSPrice Monitoring Extension
11th Oct 20167:00 amRNSTrading Update
28th Sep 20162:09 pmRNSDirectors Dealings
20th Sep 20169:16 amRNSVoting Rights and Capital
6th Sep 201612:47 pmRNSHolding(s) in Company
5th Sep 20164:40 pmRNSSecond Price Monitoring Extn
5th Sep 20164:35 pmRNSPrice Monitoring Extension
1st Sep 20167:00 amRNSBlock Listing Six Monthly Return
27th Jul 20165:21 pmRNSDirectors Dealing
27th Jul 201612:58 pmRNSResult of AGM
27th Jul 20167:00 amRNSAGM Trading Statement
15th Jul 20162:41 pmRNSDirector/PDMR Shareholding
7th Jul 20167:00 amRNSBlock listing Interim Review
30th Jun 20162:22 pmRNSHolding(s) in Company
23rd Jun 20163:28 pmRNSAnnual Financial Report
21st Jun 20166:30 pmRNSHolding(s) in Company
14th Jun 20167:00 amRNSResults for the year ended 31 March 2016
4th May 20166:22 pmRNSHolding(s) in Company
26th Apr 201610:36 amRNSHolding(s) in Company
20th Apr 20163:14 pmRNSDirector Declaration
18th Apr 20162:14 pmRNSHolding(s) in Company
15th Apr 20164:31 pmRNSHolding(s) in Company
14th Apr 20167:00 amRNSTrading Update
13th Apr 20164:06 pmRNSHolding(s) in Company
11th Apr 20169:36 amRNSHolding(s) in Company
1st Apr 20167:00 amRNSAcquisition of Abode Home Products Ltd
31st Mar 20167:00 amRNSBoard Appointment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.